# BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical Prostatectomy

> **NCT05363644** · PHASE3 · WITHDRAWN · sponsor: **AdventHealth**

## Conditions studied

- Prostate Cancer
- Prostatectomy
- Erectile Dysfunction Following Radical Prostatectomy
- Incontinence, Urinary

## Interventions

- **BIOLOGICAL:** BioDFence G3

## Key facts

- **NCT ID:** NCT05363644
- **Lead sponsor:** AdventHealth
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-04-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-06-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was withdrawn due to lack of funding
- **Last updated:** 2023-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05363644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05363644, "BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical Prostatectomy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05363644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*